EMCURE
OVERVALUEDEmcure Pharmaceuticals Limited
Pharma · NSE
↓ 33.6% vs fair value
52W Low
₹1,047
+63.8% from low
52W High
₹1,830
-6.3% from high
Valuation Gauge
Current Price
₹1,715
Fair Value
₹1,284
Fair Value Analysis
₹1,284
Based on free cash flow projections and earnings growth potential for Pharma sector companies | CAUTION: ROCE declining (latest 26.9%) — returns on capital are falling; verify this isn't a value trap. | COVID-resilient: PAT dropped from ₹209Cr (FY2019) to ₹101Cr (FY2020) during COVID but has fully recovered.
Cash Flow Analysis
38% weight
Growth Valuation
63% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Financially Healthy
Profitability
ROE of 19.6% is above the Pharma sector benchmark of 18% — strong returns
Debt & Leverage
D/E ratio of 0.3x is well within the Pharma sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 35.0x is slightly below the Pharma sector median of 42x — reasonably valued
Cash Flow
FCF margin of 4.3% — thin cash generation, watch capex trends
Earnings Growth
5yr EPS CAGR of 20.2% is in line with the Pharma sector average of 15.3%
Dividend
Dividend yield of 0.2% is symbolic — low but positive
Sentiment Trend — Last 30 Days
Historical Returns
Key Financials
EPS (TTM)
₹48.8
P/E Ratio
35x
P/B Ratio
6.6x
ROE
19.6%
ROCE
25.1%
Debt / Equity
0.31x
Beta
—
Div Yield
0.2%
FCF (Cr)
₹396 Cr
Revenue (Cr)
₹9,204 Cr
EPS Growth 5Y
20.2%
Mkt Cap (Cr)
₹32,323 Cr
52W High
₹1,830
52W Low
₹1,047
Book Value/Share
₹260.5
Financial History
Annual P&L data not available yet.
Peer Comparison
Pharma| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
Par Drugs And Chemicals Limited | ₹86.4 | ₹469.7 | +81.6% | 7.7 | 15.4% | FAIRLY_VALUED |
IOL Chemicals and Pharmaceuticals Limited | ₹118.2 | ₹237.8 | +50.3% | 26.8 | 5.2% | FAIRLY_VALUED |
Bal Pharma Limited | ₹82.3 | ₹147.5 | +44.2% | 15.7 | 12.6% | FAIRLY_VALUED |
Lincoln Pharmaceuticals Limited | ₹732.1 | ₹1,131.6 | +35.3% | 14.7 | 13.1% | FAIRLY_VALUED |
Zydus Lifesciences | ₹1,038.6 | ₹1,502.2 | +30.9% | 20.6 | 19.9% | UNDERVALUED |
Lupin | ₹2,270.7 | ₹3,112 | +27.0% | 19.5 | 26.9% | UNDERVALUED |
Natco Pharma | ₹1,170 | ₹1,571.3 | +25.5% | 13.8 | 18.0% | UNDERVALUED |
Sudeep Pharma Limited | ₹675 | ₹739.2 | +8.7% | 43.7 | 21.4% | FAIRLY_VALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Community Pulse
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant